As per the research report, the size of the North America Dermatology Diagnostic Devices Market was valued at USD 9.21 billion in 2022. It is expected to grow at a CAGR of 7.4% to reach USD 13.17 billion by 2027 during the forecast period 2022 to 2027.
The dermatological diagnostic devices market is expected to grow fast as the incidence of skin cancer and other skin ailments rises in North America, adding significantly to the increased need for dermatology equipment.
Furthermore, the popularity of these devices is fueled by rising knowledge of cosmetic procedures to boost the aesthetic appeal and technological improvements in dermatology equipment. Finally, increased disposable income is driven by the demand for dermatology devices.
Skin disease, which affects millions of individuals in North America, is one of the primary causes of the rising disease burden. A variety of skin illnesses emerge due to aging, environmental, and genetic causes. As a result, melanoma and non-melanoma skin cancers are becoming increasingly common. According to the Skin Cancer Foundation, melanoma kills over 10,130 people in the United States each year.
One of the primary factors is that the Dermatology Diagnostic Devices Market is expected to develop significantly in North America due to increased awareness about skin health. Because the skin is the largest organ in the human body, it is responsible for many human health issues.
The benefits of early identification of dermatological issues and increased awareness about skin health have created a lush ground for the growth of the dermatology diagnostic device industry.
Side effects from dermatological treatments and strict regulatory standards for medical devices are two concerns that are anticipated to slow the market's growth.
The government should develop appropriate laws and a healthy budget for medical assistance, and this equipment should be reasonable, as it is difficult for the middle class to obtain. These are the key restraints on market growth.
This research report on the North America Dermatology Diagnostic Devices Market has been segmented and sub-segmented into the following categories:
Geographically, the North America holds most of the global market share, and disposable income improved health awareness. In addition, the rising incidence of various skin disorders, primarily due to poor environmental conditions, will all help propel the dermatological diagnostic device market forward.
In North America, the rising middle class with increasing income increased healthcare spending, and considerable government measures to expand access to efficient healthcare services are expected to affect the growth of the dermatology diagnostic device market.
North America is included in the regional analysis of the dermatology diagnostic device market. Because of the rising prevalence of skin cancer and other skin disorders such as eczema and rosacea and the growing acceptance of cosmetic dermatological operations among the region's resident base, the North American dermatology diagnostic equipment industry is the region's resident base leads the global market.
Additionally, growing beauty awareness among men and women in this region is expected to be a key growth driver throughout the forecast period. The region's growing medical service industry, aided by low-cost treatment alternatives, is expected to propel the dermatology diagnostic device market forward.
The increased number of foreign businesses investing in research and development in these regions has proven to be a significant factor in the region's dermatological diagnostic device market development.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Dermatology Diagnostic Devices Market profiled in this report are 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Skin Cancer Diagnosis
5.1.3 Other Diagnostic Applications
5.1.4 Y-o-Y Growth Analysis, By Application
5.1.5 Market Attractiveness Analysis, By Application
5.1.6 Market Share Analysis, By Application
5.2.2 Imaging Devices
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3.1 Contact Oil Immersion Dermatoscopes
5.3.2 Cross-Polarized Dermatoscopes
5.3.3 Hybrid Dermatoscopes
5.3.4 Y-o-Y Growth Analysis, By Dermatoscopes
5.3.5 Market Attractiveness Analysis, By Dermatoscopes
5.3.6 Market Share Analysis, By Dermatoscopes
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Application
18.104.22.168 By Type
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Application
188.8.131.52 By Type
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Application
18.104.22.168 By Type
6.2 United States
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alma Lasers, Ltd.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cutera, Inc.
8.3 Cynosure, Inc.
8.4 Lumenis, Ltd.
8.5 Valeant Pharmaceuticals International, Inc.
8.6 3Gen, Inc.
8.7 Bruker Corporation
8.8 Carl Zeiss
8.9 Genesis Biosystems, Inc.
8.10 Heine Optotechnik GmbH & Co. Kg
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.